2Ko FW, Ip M, Chan PK, et al. Viral etiology of acute exacerbations of chronic obstruetive pulmonary disease in Hong Kong[J].Chest, 2007,132 (3) : 900 -908.
3Miyashita N, Fukano H, Mouri K, et al. Community acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study[J]. J Med Microbiol, 2005,54 (4) : 395-400.
5Seemungal T, Harper Owen R, Bhowmik A, et al. Respiratory viruses, symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med,2001,164(9):1618- 1623.
6Greenberg SB, Alien M, Wison J, et al. Respiratory viral infections in adults will, and without chronic obstructive pulmonary disease[J]. Am J Respir Crit Med, 2000,162(1): 167- 173.
7Lim WS, MacfarlaneJT, Hoswell TC, et al. Study of community acquired pneumonia aetiology in adults admitted to hospital: implications for management guidelines [J]. Thorax, 2001, 56 (4):296- 301.
3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
4Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
5Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
6Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
7Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
8Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
10Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
5British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults[J]. Thorax,2001,56(Suppl 4) : IV 1-64.
6Bleed D,Dye C, Raviglione MC, et al. Dynamics and control of the global tuberculosis epidemic [J]. Curr Opin Pulm Med, 2000,6(3) :174- 179.
7Arancibia F, Bauer TT, Ewig S, et al, Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk,and prognosis[J]. Arch Intern Med, 2002,162(16):1849- 1858.
8Kobashi Y, Ohba H, Yoneyama H, et al. Clinical analysis of patients with community-acquired pneumonia requiring hospitalization classified by aga group [J].Kansenshogaku Zasshi,2001,75(3) : 193-200.
